In conclusion, the present meta-analysis suggests that the TNF-α-238/A polymorphism is unlikely to be a risk factor for prostate cancer, while the TNF-α-308 G/A polymorphism may make a significant contribution to the risk of prostate cancer in healthy volunteers. This evidence concerns the gene TNF and prostate carcinoma.